Anti-Microbial Antibody Response is Associated With Future Onset of Crohn’s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk

Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn’s Disease

(2021) Katie L. Alexander et al.   GASTROENTEROLOGY

Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis

(2020) Joana Torres et al.   GASTROENTEROLOGY

Causal mediation analysis in nested case‐control studies using conditional logistic regression

(2020) Young Min Kim et al.   BIOMETRICAL JOURNAL

Increased Intestinal Permeability is Associated with Later Development of Crohn’s Disease

(2020) Williams Turpin et al.   GASTROENTEROLOGY

Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn’s Disease

(2019) Kirstin M. Taylor et al.   Clinical Gastroenterology and Hepatology

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

(2019) Kevan C. Herold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol

(2019) Mariam Al-Laith et al.   Trials

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

(2018) Amit V. Khera et al.   NATURE GENETICS

Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders

(2018) Symen Ligthart et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

(2017) Siew C Ng et al.   LANCET

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis

(2016) R. S. Choung et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease

(2016) Paul Lochhead et al.   Clinical Gastroenterology and Hepatology

Commensal-Specific CD4+ Cells From Patients With Crohn’s Disease Have a T-Helper 17 Inflammatory Profile

(2016) Elisabeth Calderón-Gómez et al.   GASTROENTEROLOGY

Association of host genome with intestinal microbial composition in a large healthy cohort

(2016) Williams Turpin et al.   NATURE GENETICS

A reference panel of 64,976 haplotypes for genotype imputation

(2016)   NATURE GENETICS

Next-generation genotype imputation service and methods

(2016) Sayantan Das et al.   NATURE GENETICS

Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores

(2015) Bjarni J. Vilhjálmsson et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

(2015) Jimmy Z Liu et al.   NATURE GENETICS

Immunopathogenesis of IBD: current state of the art

(2015) Heitor S. P. de Souza et al.   Nature Reviews Gastroenterology & Hepatology

Impact of disease location on fecal calprotectin levels in Crohn’s disease

(2015) Krisztina B. Gecse et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Serological markers predict inflammatory bowel disease years before the diagnosis

(2012) Fiona D M van Schaik et al.   GUT

Crohn's disease

(2012) Daniel C Baumgart et al.   LANCET

The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn’s disease

(2011) A. Eser et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children

(2008) Marla C. Dubinsky et al.   Clinical Gastroenterology and Hepatology